Nom anglais: Jumonji Domain-Containing Histone Demethylases
Descriptor UI:D056484
Tree Number:D08.811.682.690.416.388
Termes MeSH sélectionnés :
Visual Cortex
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Jumonji Domain-Containing Histone Demethylases : Questions médicales les plus fréquentes",
"headline": "Jumonji Domain-Containing Histone Demethylases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Jumonji Domain-Containing Histone Demethylases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-10",
"dateModified": "2025-04-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Jumonji Domain-Containing Histone Demethylases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dioxygenases",
"url": "https://questionsmedicales.fr/mesh/D049308",
"about": {
"@type": "MedicalCondition",
"name": "Dioxygenases",
"code": {
"@type": "MedicalCode",
"code": "D049308",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.690.416"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Jumonji Domain-Containing Histone Demethylases",
"alternateName": "Jumonji Domain-Containing Histone Demethylases",
"code": {
"@type": "MedicalCode",
"code": "D056484",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Danica Galonić Fujimori",
"url": "https://questionsmedicales.fr/author/Danica%20Galoni%C4%87%20Fujimori",
"affiliation": {
"@type": "Organization",
"name": "Department of Cellular and Molecular Pharmacology, University of California San Francisco; San Francisco, CA 94158, USA; Department of Pharmaceutical Chemistry, University of California San Francisco; San Francisco, CA 94158, USA; Quantitative Biosciences Institute (QBI), University of California San Francisco; San Francisco, CA 94158, USA. Electronic address: danica.fujimori@ucsf.edu."
}
},
{
"@type": "Person",
"name": "James E Longbotham",
"url": "https://questionsmedicales.fr/author/James%20E%20Longbotham",
"affiliation": {
"@type": "Organization",
"name": "Department of Cellular and Molecular Pharmacology, University of California San Francisco, 600 16th Street, Genentech Hall, San Francisco, California 94158, United States."
}
},
{
"@type": "Person",
"name": "Feng Li",
"url": "https://questionsmedicales.fr/author/Feng%20Li",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Biology, Key Laboratory of Cell Biology, National Health Commission of the PRC, Shenyang, China."
}
},
{
"@type": "Person",
"name": "Christopher J Schofield",
"url": "https://questionsmedicales.fr/author/Christopher%20J%20Schofield",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Research Laboratory , University of Oxford , 12 Mansfield Road , Oxford OX1 3TA , United Kingdom."
}
},
{
"@type": "Person",
"name": "Anthony Tumber",
"url": "https://questionsmedicales.fr/author/Anthony%20Tumber",
"affiliation": {
"@type": "Organization",
"name": "Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute for Antimicrobial Research, University of Oxford 12 Mansfield Road OX1 3TA Oxford UK christopher.schofield@chem.ox.ac.uk lennart.brewitz@chem.ox.ac.uk."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Neural representation of gestalt grouping and attention effect in human visual cortex.",
"datePublished": "2023-09-30",
"url": "https://questionsmedicales.fr/article/37783351",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jneumeth.2023.109980"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cortical recurrence supports resilience to sensory variance in the primary visual cortex.",
"datePublished": "2023-06-23",
"url": "https://questionsmedicales.fr/article/37353519",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s42003-023-05042-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cross-modal representation of chewing food in posterior parietal and visual cortex.",
"datePublished": "2024-10-25",
"url": "https://questionsmedicales.fr/article/39453981",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0310513"
}
},
{
"@type": "ScholarlyArticle",
"name": "Motion direction is represented as a bimodal probability distribution in the human visual cortex.",
"datePublished": "2023-11-22",
"url": "https://questionsmedicales.fr/article/37993430",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-43251-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Retinotopic connectivity maps of human visual cortex with unconstrained eye movements.",
"datePublished": "2023-08-09",
"url": "https://questionsmedicales.fr/article/37555758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/hbm.26446"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "Oxygénases",
"item": "https://questionsmedicales.fr/mesh/D010105"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dioxygenases",
"item": "https://questionsmedicales.fr/mesh/D049308"
},
{
"@type": "ListItem",
"position": 7,
"name": "Jumonji Domain-Containing Histone Demethylases",
"item": "https://questionsmedicales.fr/mesh/D056484"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Jumonji Domain-Containing Histone Demethylases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Jumonji Domain-Containing Histone Demethylases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Jumonji Domain-Containing Histone Demethylases",
"description": "Comment diagnostiquer une dysfonction des Jumonji ?\nQuels marqueurs biologiques sont associés aux Jumonji ?\nLes biopsies sont-elles utiles pour le diagnostic ?\nQuels tests sanguins sont recommandés ?\nY a-t-il des tests d'imagerie pour ces enzymes ?",
"url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Visual+Cortex&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Jumonji Domain-Containing Histone Demethylases",
"description": "Quels symptômes sont liés aux anomalies des Jumonji ?\nLes troubles neurologiques sont-ils associés ?\nY a-t-il des symptômes cutanés associés ?\nLes symptômes varient-ils selon le type de Jumonji ?\nLes symptômes sont-ils réversibles ?",
"url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Visual+Cortex&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Jumonji Domain-Containing Histone Demethylases",
"description": "Peut-on prévenir les dysfonctionnements des Jumonji ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nY a-t-il des vaccins pour prévenir ces dysfonctionnements ?\nL'éducation génétique est-elle importante ?\nLes conseils diététiques peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Visual+Cortex&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Jumonji Domain-Containing Histone Demethylases",
"description": "Quels traitements sont disponibles pour les dysfonctionnements des Jumonji ?\nLes médicaments peuvent-ils cibler les Jumonji ?\nY a-t-il des traitements naturels recommandés ?\nLes traitements sont-ils personnalisés ?\nLes thérapies combinées sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Visual+Cortex&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Jumonji Domain-Containing Histone Demethylases",
"description": "Quelles complications peuvent survenir avec les dysfonctionnements des Jumonji ?\nLes complications sont-elles graves ?\nY a-t-il des complications à long terme ?\nLes complications sont-elles réversibles ?\nLes complications varient-elles selon le type de Jumonji ?",
"url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Visual+Cortex&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Jumonji Domain-Containing Histone Demethylases",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements des Jumonji ?\nL'âge est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition à des toxines est-elle un facteur ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D056484?mesh_terms=Visual+Cortex&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des Jumonji ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses d'expression génique peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Quels marqueurs biologiques sont associés aux Jumonji ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les niveaux de méthylation des histones et l'expression des gènes sont des marqueurs clés."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les biopsies peuvent aider à évaluer l'expression des Jumonji dans les tissus."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont recommandés ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests pour mesurer les niveaux de protéines associées aux Jumonji peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Y a-t-il des tests d'imagerie pour ces enzymes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, l'imagerie ne permet pas de diagnostiquer directement les Jumonji."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés aux anomalies des Jumonji ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de croissance, des anomalies développementales et des cancers peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils associés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des dysfonctionnements neurologiques peuvent être liés à des mutations des Jumonji."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines anomalies cutanées peuvent être observées, notamment dans des syndromes spécifiques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de Jumonji ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, différents types de Jumonji peuvent entraîner des symptômes variés selon leur fonction."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils réversibles ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Cela dépend de la gravité et de la nature de la dysfonction des Jumonji."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des Jumonji ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les individus à risque de dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour prévenir ces dysfonctionnements ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il n'existe pas de vaccins spécifiques pour prévenir les dysfonctionnements des Jumonji."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques génétiques peut aider à la prévention et à la détection précoce."
}
},
{
"@type": "Question",
"name": "Les conseils diététiques peuvent-ils aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cellulaire, mais ne prévient pas directement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dysfonctionnements des Jumonji ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies géniques et des inhibiteurs spécifiques sont en cours d'étude."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils cibler les Jumonji ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments expérimentaux ciblent les Jumonji pour traiter des cancers."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels recommandés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches nutritionnelles et phytothérapeutiques sont explorées, mais peu prouvées."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction des mutations spécifiques des Jumonji."
}
},
{
"@type": "Question",
"name": "Les thérapies combinées sont-elles efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études montrent que les thérapies combinées peuvent améliorer les résultats cliniques."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les dysfonctionnements des Jumonji ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cancers, des troubles métaboliques et des anomalies développementales peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles graves ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines complications peuvent être potentiellement mortelles si non traitées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications chroniques peuvent se développer, affectant la qualité de vie."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de Jumonji ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier en fonction du type de Jumonji impliqué."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements des Jumonji ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs génétiques, environnementaux et liés au mode de vie peuvent influencer le risque."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains dysfonctionnements des Jumonji sont plus fréquents avec l'âge."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines est-elle un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines peut augmenter le risque de dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie malsain peut accroître le risque de dysfonctionnements des Jumonji."
}
}
]
}
]
}
The brain aggregates meaningless local sensory elements to form meaningful global patterns in a process called perceptual grouping. Current brain imaging studies have found that neural activities in V...
We adopted MVPA to decode the specific content of perceptual grouping by comparing neural activity patterns between gratings and dot lattice stimuli which can be grouped with proximity law. Furthermor...
We found that activity patterns to proximity grouped stimuli in early visual areas resemble these to grating stimuli with the same orientations. This similarity exists even when there is no attention ...
Most of the previous work on perceptual grouping has focused on how activity amplitudes are modulated by grouping. Using MVPA, the present work successfully decoded the contents of neural activity pat...
Our work found that the content of the neural activity patterns during perceptual grouping can be decoded in the early visual areas under both attended and unattended task, and provide novel evidence ...
Our daily endeavors occur in a complex visual environment, whose intrinsic variability challenges the way we integrate information to make decisions. By processing myriads of parallel sensory inputs, ...
Even though the oral cavity is not visible, food chewing can be performed without damaging the tongue, oral mucosa, or other intraoral parts, with cross-modal perception of chewing possibly critical f...
Humans infer motion direction from noisy sensory signals. We hypothesize that to make these inferences more precise, the visual system computes motion direction not only from velocity but also spatial...
Human visual cortex contains topographic visual field maps whose organization can be revealed with retinotopic mapping. Unfortunately, constraints posed by standard mapping hinder its use in patients,...
Previous research has shown that neural activity in the primary visual cortex (V1) and V1 surface area may be linked with subjective experience of size illusions. Here, we behaviorally measured the ha...
Bartolomeo Panizza (1785-1867) was an eminent anatomist and a pupil of Antonio Scarpa (1752-1832) at the University of Pavia. In 1855, before the revolutionary studies of Paul Broca (1824-1880) on aph...
Long-term potentiation (LTP) is a form of neuroplasticity commonly implicated in mechanistic models of learning and memory. Acute exercise can boost LTP in the motor cortex, and is associated with a s...
Perceptual difficulty is sometimes used to manipulate selective attention. However, these two factors are logically distinct. Selective attention is defined by priority given to specific stimuli based...
A person's cognitive state determines how their brain responds to visual stimuli. The most common such effect is a response enhancement when stimuli are task relevant and attended rather than ignored....